CCycling Read More Richard Scolyer cycled 500km in four days just weeks before he diedJune 15, 2026 On the first day of the epic fundraising bike ride that Richard Scolyer undertook just 11 weeks before…
HHealth Read More Vaping devices and flavors affect genes differentlyJune 4, 2026 Not all vaping exposures are the same: researchers reveal that device generation, flavor choices, and vaping intensity each…
HHealth Read More Fewer radiotherapy sessions for prostate cancer show minimal side effectsMay 17, 2026 Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five…
HHealth Read More Scientists identify methylphenidate as an effective tool for combating chronic cancer related fatigueMay 14, 2026 A new meta-analysis in the May 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network provides updated…
SScience Read More Chromosome abnormalities may help cancer cells resist treatment and spreadMay 8, 2026 A new study led by NYU Langone Health researchers found that cancer cells are better able to resist…
NNutrition Read More This Popular Supplement May Interfere With Cancer Treatment, Scientists WarnApril 30, 2026 A common vitamin taken for hair regrowth may quietly distort key medical test results in cancer patients. Credit:…
HHealth Read More How cost, access, and awareness barriers are slowing BRCA testingApril 29, 2026 Despite broader guidelines and life-saving targeted therapies, real-world evidence reveals persistent gaps and inequities in BRCA testing, raising…
HHealth Read More HPV vaccine for boys halves their risk of multiple cancers, JAMA study suggestsApril 24, 2026 Vaccinating young men against HPV reduces their risk of HPV-related cancers by almost half, a retrospective cohort study…
SScience Read More Methylation-sensitive Cas9 can selectively target DNA in tumor cellsApril 18, 2026 CRISPR-Cas gene-editing tools have revolutionized the world of biotechnology and medicine. And each year, it seems, these…
SScience Read More ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discoveryApril 15, 2026 ORGAPRED, a France-based core facility specializing in Patient-Derived Tumor Organoid (PDTO) research, has selected the CYTOQUBE high-throughput 3D…
HHealthcare Read More Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costingApril 8, 2026 Kazdal D, Endris V, Allgauer M, Kriegsmann M, Leichsenring J, Volckmar AL, et al. Spatial and temporal heterogeneity…
HHealth Read More New smart drugs precisely target and kill cancer cellsApril 3, 2026 Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting…